Eclipse Regenesis: Funding, Investors & Team (Oct 2026)
Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities to treat important diseases. Its flagship product, the Eclipse XL1 System™, utilizes distraction enterogenesis in a treatment designed to mechanically stimulate the body to produce new, fully-functional intestinal to address Short Bowel Syndrome (SBS). With the support of more than 15 years of scientific research and the participation of SBS thought leaders from around the world, the Eclipse Regenesis team is passionate about pioneering a restorative therapy for a disease state that has no cure today. The Eclipse XL1 System is an investigational device and is not currently available commercially in any region.
Eclipse Regenesis has raised $1.7M across 1 funding round on record, the most recent a Grant of $1.7M announced in Aug 2021.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Eclipse Regenesis Company Profile and Key Stats
Latest funding round on record: Aug 2021.
Eclipse Regenesis Funding Rounds
Eclipse Regenesis Founders and Leadership Team
Contact details for the Eclipse Regenesis team: 1 of 1 has an email address on file.
Start 14-day free trial →Eclipse Regenesis Funding Compared to Other Health Care Startups
Eclipse Regenesis' latest round of $1.7M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eclipse Regenesis in Health Care and Menlo Park
Companies Similar to Eclipse Regenesis
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Eclipse Regenesis Funding FAQs
What does Eclipse Regenesis do?
Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities to treat important diseases. Its flagship product, the Eclipse XL1 System™, utilizes distraction enterogenesis in a treatment designed to mechanically stimulate the body to produce new, fully-functional intestinal to address Short Bowel Syndrome (SBS). With the support of more than 15 years of scientific research and the participation of SBS thought leaders from around the world, the Eclipse Regenesis team is passionate about pioneering a restorative therapy for a disease state that has no cure today. The Eclipse XL1 System is an investigational device and is not currently available commercially in any region.
How much funding has Eclipse Regenesis raised?
Eclipse Regenesis has raised $1.7M across 1 round on record. The most recent is a Grant of $1.7M announced in Aug 2021.
When did Eclipse Regenesis last raise funding?
Eclipse Regenesis' most recent funding round on record is a Grant of $1.7M, announced in Aug 2021.
Who is the CEO of Eclipse Regenesis?
Andre Bessette is listed as CEO at Eclipse Regenesis.
Where is Eclipse Regenesis headquartered?
Eclipse Regenesis is based in Menlo Park, California, United States.
How many employees does Eclipse Regenesis have?
Eclipse Regenesis is in the 1-10 employee band.
How does Eclipse Regenesis' funding compare to other Health Care startups?
Eclipse Regenesis' latest round of $1.7M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Eclipse Regenesis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eclipse Regenesis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.